NCT03544723 2020-06-09
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
MultiVir, Inc.
Phase 2 Unknown
MultiVir, Inc.
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Introgen Therapeutics